An AMAZING #IKCSEU26 in Paris 🇫🇷 France
Thanking our partners at Kindey Cancer Association, our ambassadors, our colleagues worldwide who were reporting live on the great discussions and all those colleagues at home following along. A warm welcome to Join #IKCS26 in Dallas Texas this coming November
DAY THREE of OncoAlert 🚨 Coverage of #IKCSEU26
The Meet-URO Score Presenter Dr. Sara Rebuzzi 🇮🇹
The Meet-URO score is a novel prognostic tool for metastatic renal cell carcinoma, integrating the IMDC score with neutrophil-to-lymphocyte ratio and presence of bone metastases.
DAY THREE of OncoAlert 🚨 Coverage of #IKCSEU26
Triplet Therapy in First Line ccRCC Presenter Dr. Yüksel Ürün 🇹🇷
KEYMAKER-U03A: in kidney cancer, more is not more. Mechanism matters.
There is a signal. It will not change practice yet.
Waiting for LITESPARK-012.
DAY THREE of OncoAlert 🚨 Coverage of #IKCSEU26
CkOSMIC - One stop renal tumor diagnostic clinic Presenter Dr.Chiara Re 🇮🇹
CkOSMIC rethinks kidney cancer care. The first one-stop renal mass biopsy clinic delivering: - Same-day diagnosis & treatment plan - 94% sensitivity / 100%
Dear Colleagues,
OncoAlert Would like to Congratulate Kidney Cancer Association and all the faculty and staff who are making #IKCSEU26 🇫🇷 Possible.
Amazing Stats, Not even the close of the meeting and it has already OVER 4x the #IKCSEU26 and we are just getting Started
6️⃣ .6️⃣million Impressions
DAY THREE of OncoAlert 🚨 Coverage of #IKCSEU26
M1 - Defining subtype-specific PD-1, PD-L1 and CTLA-4 immunopositivity thresholds for personalized prognostication in surgically treated non-metastatic renal cell carcinoma Presenter Dr. Selcuc Erdem 🇹🇷
DAY THREE of OncoAlert 🚨 Coverage of #IKCSEU26
Microbiome impacting therapy with inulin gel in combination with ipilimumab and nivolumab in advanced renal cell carcinoma: ICON trial Dr. Ulka Vaishampayan 🇺🇸
We were proud to hear CARE1 referenced during the session “Navigating the Maze: Clinical Trials and Second‑Line Therapy Decisions" at #IKCSEU26!
Many thanks to Bernard Escudier, member of our Patient Advisory Board, for bringing his experience and perspective!
#CARE1 #Project ClinicalResearch
Our Warmest congratulations to our @OncoAlert 🚨 faculty Dr. John Haanen 🇳🇱 on being awarded the N. Vogelzang Humanitarian Award at #IKCSEU26 🇫🇷
Kudos John!!!
DAY THREE of OncoAlert 🚨 Coverage of #IKCSEU26
Characteristics and outcome of pediatric renal tumors Presenter Dr. Marry M van den Heuvel-Eibrink 🇳🇱
Children and adults, both can suffer from kidney cancer. Important cancer types as Wilms tumor and Renal Cell Carcinoma.
DAY THREE of OncoAlert 🚨 Coverage of #IKCSEU26
KCA Updates by Salvatore La Rosa🇺🇸
The future of kidney cancer isn’t just presented—it’s built together. IKCS continues to evolve into a platform for collaboration, where ideas are tested, partnerships are formed, and science moves closer to patients.
Dear Colleagues
An Amazing START to the final day of #IKCSEU26 !!
✅5.2 million impressions and Counting
www.medtracksocial.com/hashtag/
Thanks to our partners at @KidneyCancer for a magnificent meetings and to our colleagues from keeping us up to date in real time
We are all OncoAlert 🚨
IKCC board members were on stage this morning at #IKCSEU26 in Paris for the session on the RCC patient experience. Claudia Ungarelli (Vice-Chair of IKCC) made a presentation “From Watching to Acting: A Journey from Surveillance to Treatment”. (1/3)
DAY TWO of OncoAlert 🚨 Coverage of #IKCSEU26
The management of renal manifestations in vhl syndrome: insights from a single institution's three-decade experience Presenter Dr. Selcuc Erdem 🇹🇷
Day TWO of OncoAlert 🚨 Coverage of #IKCSEU26
L3 - The accuracy of KEYNOTE-564 study eligibility criteria on recurrence prediction in papillary renal cell carcinoma: A multi-institutional comparative analysis with prognostic scores Presenter Dr. Selcuc Erdem 🇹🇷
DAY Two of OncoAlert 🚨 Coverage of #IKCSEU26
Leading Across Time: Women's Empowerment Legacy and the future of Oncology (Women and Allies in RCC session) Presenter Dr. Athina Christopoulou 🇬🇷
Empowering women’s leadership strengthens innovation, improves patient outcomes, and is essential!
DAY TWO of OncoAlert 🚨 Coverage of #IKCSEU26
Farnesyl transferase inhibitor (FTI) darlifarnib (KO-2806) combined with cabozantinib (cabo) in clear cell renal cell carcinoma (ccRCC) patients after prior exposure to cabo: Preliminary phase 1 results from FIT-001 Presenter Dr. Yousef Zakharia 🇺🇸
DAY TWO of OncoAlert 🚨 Coverage of #IKCSEU26
Preoperative risk prediction tool for cancer-specific and other cause mortality after surgery for non-metastatic renal cell carcinoma Presenter Dr. Philip Hedegaard 🇩🇰
DAY TWO of OncoAlert 🚨 Coverage of #IKCSEU26
Impact of intratumoral tertiary lymphoid structures on response and toxicity to immune checkpoint inhibitors from the bionikk trial in metastatic ccRCC
Presenter Dr. Isaias Hernandez-Verdin 🇫🇷
Great Discussions Happening at #IKCSEU26 in Beautiful Paris🇫🇷
Unfolding insights to RCC #KidneyCancer
DAY TWO of OncoAlert 🚨 Coverage of #IKCSEU26
Trial Resilience: Learning from Negative Outcomes Presenter Dr. Antonio Rullan 🇬🇧
Clinical trials with negative results are unfortunately too frequent. In this talk we discussed learning points from IMMOTION 151, CHECKMATE 914 and PROSPER
At #IKCSEU26, Olivier Exertier highlighted the amazing contribution of patient representatives like @ikccorg.bsky.social and Asso ARTuR in designing EU‑funded programmes such as #CARE1Project.
@oncoalert.bsky.social
#KidneyCancerAssociation
@actionkidneycancer.bsky.social
DAY TWO of OncoAlert 🚨 Coverage of #IKCSEU26
Quality of Life and Survivorship with Adjuvant Immunotherapy: Insights From the Patient Experience Presenter Dr. Sophie Merrick 🇬🇧
Adjuvant ICIs are now standard of care in resected RCC, so understanding their impact on quality of life is essential.
DAY TWO of OncoAlert 🚨 Coverage of #IKCSEU26
Treatment Barriers and Shared Decision-Making Disparities in Kidney Cancer Across Europe: Results from the IKCC Global Patient Survey Presenter Dr. Eric Jonasch 🇺🇸
DAY One of OncoAlert 🚨 Coverage of #IKCSEU26
PreClinical Session Setting the Scientific Stage Tumor Microenvironment Translational Research in RCC Presenter Dr. Daniyal Jafree 🇬🇧
Showing how AI can transform spatial profiling in kidney cancer
We are only a Few Days away from #IKCSEU26 in beautiful Paris France🇫🇷 There is still time register and join us for some great days of Science and friendships.
👉 web.cvent.com/event/9d248a...
See you There!!
